Key facts
- It has raised $2.4M across 2 recorded rounds; the latest was Seed Round ($3.1M) in Jan 2025.
- Retropsoas Technologies has filed 6 Form Ds with the SEC since 2020, most recently Aug 2025 ($1.1M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Retropsoas Technologies
Funding rounds
2 roundsAbout Retropsoas Technologies
Developer of healthcare technologies designed for clinical and diagnostic advancement. The company focuses on creating tools that support medical professionals through data-driven insights, imaging, and patient-specific modeling, enabling healthcare providers to improve diagnostic accuracy, enhance treatment planning, and deliver effective care across various medical disciplines.
- Sector
- Healthcare
- HQ
- Frontenac, MO, United States
- Founded
- 2017
- Website
- retropsoas.com/
- Ownership
- Privately Held (backing)
Retropsoas Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Retropsoas Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Retropsoas Technologies in its N-PORT filings yet. We sweep new filings monthly.